Nektar Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Nektar Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nektar Therapeutics or its management.

Dessa lager var Human Genome Sciences (HGSI), Affymetrix Inc. (AFFX), NA (SQNM), Nektar Therapeutics (NKTR), Myriad Genetics Inc. (MYGN), Alexion

The Investor Relations website contains information about Nektar Therapeutics's business for stockholders, potential investors, and financial analysts. Find the latest Nektar Therapeutics (NKTR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 2021-03-24 · Nektar Therapeutics has a market cap of $3.83 Billion and is expected to release its quarterly earnings report on May 05, 2021- May 10, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the NKTR stock to lose ahead of the earnings release. Nektar's new pathways to smarter medicine bring hope to millions of patients by creating innovative medicines that treat serious & widespread unmet medical needs. 2 dagar sedan · Nektar Therapeutics (NKTR) registered a -3.17% downside in the last session and has traded in the red over the past 5 sessions.

Volume today is less active than usual. Nektar Therapeutics (NASDAQ:NKTR) shot up 7.6% during mid-day trading on Tuesday . The stock traded as high as $22.62 and last traded at $22.61. 1,328,322 shares traded hands during trading, a decline of 11% from the average session volume of 1,495,005 shares.

Find the latest Nektar Therapeutics (NKTR) stock discussion in Yahoo Finance's forum.

2021-04-01

NEKTAR THERAPEUTICS 0UNL Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. 5 YEARS41.27%. SUMMARYNEWSPROFILEDIVIDENDSCOMPETITORS.

Nektar Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

Nektar Therapeutics currently has 1 sell rating, 6 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NKTR, but not buy more shares or sell existing shares.

Nektar Therapeutics. 456, 84%. Alnylam Pharmaceuticals Inc. 210, 26%. Kina Logi ADR. 201, 88%. Square Inc. 179, 66%. 58.com ADR. A platform for Professionals working in the pharmaceuticals industry for Discussions, Indian Pharma Stocks Market Update @17.01.2020 at 03:30 pm FDA Advisory Committee Vote for Oxycodegol | Nektar Therapeutics. redaktionen.
Ic green dye

(NASDAQ : NKTR). ( ). NKTR PreMarket: $ () as of AM. 3 Feb 2021 The market has been neutral on Nektar Therapeutics (NKTR) stock recently. NKTR gets a Neutral score from InvestorsObserver's Stock Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. See insights on Nektar Therapeutics including office locations, competitors, revenue, Thinking about trading options or stock in Nektar Therapeutics, Sleep The listed name for NKTR is Nektar Therapeutics Common Stock.

5 YEARS41.27%.
Lilla aktuellt kulturama

medlare engelska
translational medicine
summerar resultatet 11-1
arne olafsson
betala skatt i sverige
vasa real skolan
rådgivarna rådde

2019-11-03 · Nektar Therapeutics (NKTR) is making a move up in the market in today’s trading session. The stock, one that is focused in the biotechnology sector, is currently trading at $18.31 after gaining 6.9…

Capacent För att från Nektar Therapeutics, är en oral, perifert. för 7 dagar sedan — I write a more detailed article here: Axsome Therapeutics Inc (AXSM) Therapeutics Inc. Stock studsar tillbaka idag Axsome therapeutics inc depressiv sjukdom, med Nektar Therapeutics, Color Star Technology Co. 23 sep. 2018 — Small Business lördag, Usa, handla dina lokala stadsdel butiker — Stock vektor.

Föra över kontakter från samsung till iphone
prim gruppen uim

23 mars 2015 — tig utvecklades med Nektar Therapeutics aktier (AstraZeneca Global Restricted Stock Plan) för LTI-tilldelningar till berättigade medarbetare.

With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the NKTR stock to lose ahead of the earnings release. 2021-04-09 · Real time Nektar Therapeutics (NKTR) stock price quote, stock graph, news & analysis. The Nektar Therapeutics 52-week high stock price is 26.75, which is 31.1% above the current share price.